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Introduction

Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide, accounting for 90% of all liver carcinomas. HCC has a high mortality rate, as many tumours are asymptomatic until the later stages [1] Like many other forms of cancer, HCC overexpress transforming growth factor-␤1 (TGF-␤1) [2]. TGF-␤1 is a member of a family of cytokines that controls several aspects of cell behaviour such as proliferation, migration, adhesion, differentiation and immune function. In early stages of tumour development TGF-␤ has tumour suppressive activity, while during advanced stages it promotes growth, invasiveness and dissemination of tumour cells
 [3] [4] [5] [6] 
. Based on the dual effects of TGF-␤ on oncogenesis, a recent study from our laboratory demonstrated that gene expression signature discriminates early and late effects of TGF-␤ in HCC, thus establishing a reliable molecular classification of tumours as a new basis for targeted therapy
. [6, [8] [9] [10] . During the neoplastic process many tumour cells acquire resistance to the antiproliferative signals of TGF-␤ [4] . The absence of TGF-␤ inhibitory effect on cell growth correlates with loss of TGF␤RI and/or TGF␤RII [11] .
TGF-␤ elicits its effect through two transmembrane serine/threonine kinase receptors, TGF␤RI and TGF␤RII. After binding TGF-␤, the TGF␤RII phosphorylates the TGF␤RI receptor, which then phosphorylates the intracellular Smad proteins that serve as effectors
Hep3B-TS, a well-characterized HCC cell line, is sensitive to the inhibitory effect of TGF-␤ on cell proliferation. In an elegant experiment [11] 
Materials and methods
Cell culture
Hep3B-TS and Hep3B-TR cell lines were grown in DMEM/F12 medium supplemented with glutamine (2 mM) and 10% foetal bovine serum. Both cell lines were negative for mycoplasma.
Conventional fluorescence in situ hybridization
Cells were treated with colcemid for 4 hrs and chromosome preparations were made according to standard protocols. For fluorescent in situ hybridization (FISH), chromosomes spreads were hybridized with a biotin labelled-TGF␤RII genomic probe as previously described [12] . Detection of the hybridization signal, digital image acquisition, and analysis were carried out as previously described [13] .
Spectral karyotyping
Chromosome hybridization and analysis for spectral karyotyping (SKY) were conducted according to a standard protocol with minor modifications [14] 
Northern blot analysis
The expression TGF␤RII mRNA was examined by Northern blot hybridization as previously described [15] .
Microarray-based expression analysis
The (Fig. 1B) , Hep3B-TR cells showed only one apparently normal chromosome 3 (Fig. 1C) , but neither fluorescent signals in FISH with TGF␤RII probe, nor the presence of TGF␤RII RNA in Northern-blot analysis were detected (Fig. 1D) . Fig. 2A) showed abnormal karyotype nearly identical to that reported by others [18] Fig. 2A, B) and their respective aCGH profiles of genomic imbalances (Fig. 2B, D (Fig. 3B) , which affected a region spanning from 26.6MB to 31.2MB and effectively erased the only remaining copy of the TGF␤RII gene (Fig. 3C) .
Like in other HCC cell lines, the SKY analysis of Hep3B-TS cell line (
, with a near triploid chromosome number and multiple complex structural and numerical alterations that left just a few chromosomes with normal appearance. Yet, a comparison of our chromosomal CGH analysis of Hep3B-TS cells from 1999 (12) with microarray-based CGH data obtained in this study -after several extended culturing episodes in the meantime -points to a marked genomic stability of this cell line. Although TGF-␤-resistant Hep3B-TR cells (Fig. 2C) retained most of the structural and numerical abnormalities seen in Hep3B-TS cells, several new and complex alterations, such as translocations t(2; X) and t(2; 18), occurred as a result of exposure to TGF-␤ during selection of TGF-␤-resistant cells. We found a remarkable concordance between SKY karyotypes of Hep3B-TS and Hep3B-TR cells (
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Fig. 1 FISH and Northern blot analysis of Hep3B-TS and Hep3B-TR cells. Status of chromosome 3 in Hep3B-TS (A) and Hep3B-TR (C) was examined by FISH with whole chromosome 3 painting probe. Whereas Hep3B-TS cells exhibit two sets of TGF␤RII signals (B) Hep3B-TR cells show no hybridization signals and no TGF␤RII RNA (D).
Expression profiling of Hep3B-TS and Hep3B-TR; TGF-␤ resistance activates TNF pathway
Using an oligonucleotide microarray of 21 Cell proliferation, migration, anchorage independent growth in vitro, and tumorigenicity in vivo associated with loss of TGF␤RII and TGF-␤-resistance (Fig. 5A) [19] , CCL20 (chemokine ligand 200 [20] , CXCL10 (chemokine ligand 10) [21] and BF (B-factor, properdin) [22] [7, 27] .
To see whether loss of TGF␤RII influenced tumour cell behaviour, we compared the in vitro cell proliferation, migration and ability to form colonies in soft agar and in vivo tumorigenicity of two cell lines. We found that Hep3B-TS grew considerably slower than Hep3B-TR cells over a period of 10 days in culture, and that the migratory behaviour of the cells was also different
Despite the complexity of TGF-␤ signalling in oncogenesis, many components of the TGF-␤ pathway have been characterized, thus allowing the identification of markers for diagnosis and prognosis of certain cancers as well as for providing molecular targets for some subset of cancers [3, 6] . Given our limited knowledge of the factors that mediated the switch between the tumour promoter and suppressor functions of TGF-␤, it currently appears that immune cells from the tumour host may hold the best prospects for a novel therapeutic approach for advanced cancer [28] .
